Assessment of chemotherapy‐induced neurotoxicity using a point‐of‐care nerve conduction study device

BACKGROUND: Management for chemotherapy‐induced peripheral neuropathy (CIPN) includes prompt recognition and dose reduction or discontinuation of the neurotoxic agents. CIPN remains under‐detected in routine clinical practice and better methods for its early detection are warranted. AIMS: To evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales: Jokimäki, Anna, Iivanainen, Sanna, Mikkonen, Raija, Mika, Kallio, Koivunen, Jussi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875618/
https://www.ncbi.nlm.nih.gov/pubmed/35818348
http://dx.doi.org/10.1002/cnr2.1677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875618/
https://www.ncbi.nlm.nih.gov/pubmed/35818348
http://dx.doi.org/10.1002/cnr2.1677

Ejemplares similares